ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Vaxelis 0.5 ml, Injektionssuspension - 10
66940002 Future Health Pharma GmbH
Vaxelis 0.5 ml, Injektionssuspension28.08.2019
  28.08.2019
Diphtheria-Haemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B (J07CA09) 
WHO-DDD 
08.08.10
08.08. 
B  
No 
IP 
PR  
k.A.PR
  
7680669400026Impfstoffe
  
Composition
polysaccharida haemophili influenzae typus B conjugata cum proteino neisseriae meningitidis B 53 µg corresp. polysaccharida haemophili influenzae typus B 3 µg et neisseria meningitidis B outer membrane protein complex 50 µg, hepatitidis B viri antigenum ADNr 10 µg, toxoidum pertussis 20 µg, haemagglutininum filamentosum 20 µg, pertactinum 3 µg, fimbriae Typ 2 und 3 5 µg, toxoidum diphtheriae min. 20 U.I., toxoidum tetani min. 40 U.I., virus poliomyelitis typus 1 inactivatus (Mahoney) 40 U., virus poliomyelitis typus 2 inactivatus (MEF-1) 8 U., virus poliomyelitis typus 3 inactivatus (Saukett) 32 U., aluminium ut aluminii phosphas et aluminii hydroxyphosphas sulfas amorphus, natrii phosphates, acidum hydrochloridum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.95 mg, residui: glutaralum, formaldehydum, neomycinum, streptomycinum, polymyxinum B, albuminum seri bovis, aluminii thiocyanas, faecis proteina.
Packungsbestandteile
Injection suspension 
  
 
Active AgentDose
 20 µg
 10 µg
Pertactin3 µg
 53 µg correspond  3 µg
 20 UI
 20 µg
 40 UI
 40 U
 8 U
 32 U
BAG: Active AgentDose
 5 mcg
 20 mcg
 3 mcg
 3 mcg
 20 mcg
 20 UI
 10 mcg
 40 UI
 40 U
 8 U
 32 U
 
Inactive agentsDose
  
  
Alumine 
 2
  
 50 µg
 5 µg
 
Source
Data was imported : 06.02.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home